Carmen Terán

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 7

Top Topics

Single Molecule

Induced Pluripotent Stem Cells

Molecular Docking

Top Venues

Molecules (Basel, Switzerland)

Future medicinal chemistry

ACS medicinal chemistry letters

This page only lists publications with an associated author ORCID identifier.

Publications

Noemí Vila, Pedro Besada, Jose Brea, María Isabel Loza, Carmen Terán
Novel Phthalazin-1(2H)-One Derivatives Displaying a Dithiocarbamate Moiety as Potential Anticancer Agents. Molecules (Basel, Switzerland) 27 (23) (2022)
Noemí Vila, Pedro Besada, Jose Brea, María Isabel Loza, Carmen Terán
Novel Phthalazin-1(2H)-One Derivatives Displaying a Dithiocarbamate Moiety as Potential Anticancer Agents. Molecules (Basel, Switzerland) 27 (23) (2022)
María Carmen Costas-Lago, Noemí Vila, Adeyemi Rahman, Pedro Besada, Isabel Rozas, José Brea, Maria Isabel Loza, Elisa González Romero, Carmen Terán
Novel Pyridazin-3(2 H )-one-Based Guanidine Derivatives as Potential DNA Minor Groove Binders with Anticancer Activity. ACS medicinal chemistry letters 13 (3) (2022)
Noemí Vila, Pedro Besada, Jose Brea, María Isabel Loza, Carmen Terán
Novel Phthalazin-1(2H)-One Derivatives Displaying a Dithiocarbamate Moiety as Potential Anticancer Agents. Molecules (Basel, Switzerland) 27 (23) (2022)
Noemí Vila, Pedro Besada, Jose Brea, María Isabel Loza, Carmen Terán
Novel Phthalazin-1(2H)-One Derivatives Displaying a Dithiocarbamate Moiety as Potential Anticancer Agents. Molecules (Basel, Switzerland) 27 (23) (2022)
Pedro Besada, María Gallardo-Gómez, Tania Pérez-Márquez, Lucía Patiño-Álvarez, Sergio Pantano, Carlos Silva López, Carmen Terán, Ana Arévalo-Gómez, Aurora Ruz-Zafra, Julián Fernández-Martín, Saida Ortolano
The New Pharmacological Chaperones PBXs Increase α-Galactosidase A Activity in Fabry Disease Cellular Models. Biomolecules 11 (12) (2021)
María C Costas-Lago, Pedro Besada, Ernesto Cano, Carmen Terán
Novel compounds of hybrid structure pyridazinone-coumarin as potent inhibitors of platelet aggregation. Future medicinal chemistry 11 (16) (2020)